Literature DB >> 9888641

Non-esterified fatty acid metabolism and postprandial lipaemia.

K N Frayn1.   

Abstract

Non-esterified fatty acids (NEFA, or free fatty acids) are an important metabolic fuel. Both the concentration of NEFA and their flux through the circulation vary widely from hour to hour, reflecting nutritional state and physical activity. Inappropriately elevated plasma NEFA concentrations may have a number of adverse effects on both carbohydrate and lipid metabolism. These adverse effects are likely to be most marked in the postprandial period, when NEFA release from adipose tissue is usually suppressed. Although the regulation of NEFA release in the postabsorptive state is well understood in molecular terms, the predominant pathway for release of NEFA in the postprandial state is the action of lipoprotein lipase (LPL) in adipose tissue capillaries on chylomicron-triacylglycerol (TG). Fatty acids released by LPL may either be sequestered in the adipocytes by esterification, or released as NEFA into the plasma. The regulation of this branch-point, which may be of crucial significance for postprandial metabolism, is not well understood. Factors stimulating tissue retention of fatty acids include insulin and acylation stimulating protein. There is considerable indirect evidence that impaired regulation of this step occurs in insulin resistance and other conditions collectively recognised by an elevated concentration of apolipoprotein B (hyper-apo B). Inappropriate release of NEFA in the postprandial period is likely both to reduce the sensitivity of glucose metabolism to insulin and to accentuate postprandial lipaemia. Further study of the regulation of this pathway is much needed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888641     DOI: 10.1016/s0021-9150(98)00216-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Postprandial lipid responses to an alpha-linolenic acid-rich oil, olive oil and butter in women: a randomized crossover trial.

Authors:  Julia Svensson; Anna Rosenquist; Lena Ohlsson
Journal:  Lipids Health Dis       Date:  2011-06-28       Impact factor: 3.876

Review 3.  Postprandial energy metabolism in the regulation of body weight: is there a mechanistic role for dietary calcium?

Authors:  Mario J Soares; Wendy L Chan She-Ping-Delfos
Journal:  Nutrients       Date:  2010-05-28       Impact factor: 5.717

4.  Liver circadian clock disruption alters perivascular adipose tissue gene expression and aortic function in mice.

Authors:  Paramita Pati; Jennifer A Valcin; Dingguo Zhang; Thomas H Neder; Telisha Millender-Swain; John Miller Allan; Randee Sedaka; Chunhua Jin; Bryan K Becker; David M Pollock; Shannon M Bailey; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-21       Impact factor: 3.210

5.  Molecular Fingerprints of Iron Parameters among a Population-Based Sample.

Authors:  Anne Kaul; Annette Masuch; Kathrin Budde; Gabi Kastenmüller; Anna Artati; Jerzy Adamski; Henry Völzke; Matthias Nauck; Nele Friedrich; Maik Pietzner
Journal:  Nutrients       Date:  2018-11-19       Impact factor: 5.717

Review 6.  Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.

Authors:  Jeetesh V Patel; Inessa Tracey; Elizabeth A Hughes; Gregory Y H Lip
Journal:  Vasc Health Risk Manag       Date:  2009-09-24

7.  High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2α concentrations relative to a control high-oleic acid meal: a randomized controlled trial.

Authors:  Robert Purcell; Sally H Latham; Kathleen M Botham; Wendy L Hall; Caroline P D Wheeler-Jones
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.